209 related articles for article (PubMed ID: 28614959)
1. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.
Wang X; Zhang X; Liu F; Wang M; Qin S
Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959
[TBL] [Abstract][Full Text] [Related]
2. Effects of puerarin on the pharmacokinetics of triptolide in rats.
Wang Q; Wu Y; Xiang F; Feng Y; Li Z; Ding Y
Pharm Biol; 2019 Dec; 57(1):407-411. PubMed ID: 31230510
[No Abstract] [Full Text] [Related]
3. Effects of triptolide on pharmacokinetics of fenofibrate in rats and its potential mechanism.
Li T; Liu J; Zheng Y; Yang S; Liu X; Li X
Xenobiotica; 2019 Feb; 49(2):211-215. PubMed ID: 29412757
[TBL] [Abstract][Full Text] [Related]
4. Effects of triptolide on the pharmacokinetics of cyclophosphamide in rats: a possible role of cytochrome P3A4 inhibition.
Zhang XF; Liu J; Ye F; Ji SG; Zhang N; Cao RS; He L; Wu JC; Li XF
Chin J Integr Med; 2014 Jul; 20(7):534-9. PubMed ID: 24420925
[TBL] [Abstract][Full Text] [Related]
5. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects.
Huang F; Ajavon A; Huang E; Lettieri J; Liu R; Peña C; Berse M
Thyroid; 2017 Sep; 27(9):1118-1127. PubMed ID: 28741453
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice.
Edginton AN; Zimmerman EI; Vasilyeva A; Baker SD; Panetta JC
Cancer Chemother Pharmacol; 2016 May; 77(5):1039-52. PubMed ID: 27053087
[TBL] [Abstract][Full Text] [Related]
7. Influence of grapefruit juice on pharmacokinetics of triptolide in rats grapefruit juice on the effects of triptolide.
Jia Y; Liu J; Xu J
Xenobiotica; 2018 Apr; 48(4):407-411. PubMed ID: 28359180
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver.
Murray M; Gillani TB; Ghassabian S; Edwards RJ; Rawling T
Eur J Pharm Sci; 2018 Mar; 114():55-63. PubMed ID: 29223619
[TBL] [Abstract][Full Text] [Related]
9. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
Zhao M; Lee SH; Song JG; Kim HY; Han HK
Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.
Parvinian A; Casadaban LC; Hauck ZZ; van Breemen RB; Gaba RC
Diagn Interv Radiol; 2015; 21(3):235-40. PubMed ID: 25835078
[TBL] [Abstract][Full Text] [Related]
11. Use of transgenic mouse models to understand the oral disposition and drug-drug interaction potential of cobimetinib, a MEK inhibitor.
Choo EF; Woolsey S; DeMent K; Ly J; Messick K; Qin A; Takahashi R
Drug Metab Dispos; 2015 Jun; 43(6):864-9. PubMed ID: 25813936
[TBL] [Abstract][Full Text] [Related]
12. Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS.
Zhang C; Gao Z; Niu L; Chen X
Pharm Biol; 2018 Dec; 56(1):132-137. PubMed ID: 29385884
[TBL] [Abstract][Full Text] [Related]
13. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
Gong X; Chen Y; Wu Y
Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
[TBL] [Abstract][Full Text] [Related]
14. Herb-Drug Interaction between the Traditional Hepatoprotective Formulation and Sorafenib on Hepatotoxicity, Histopathology and Pharmacokinetics in Rats.
Ting CT; Cheng YY; Tsai TH
Molecules; 2017 Jun; 22(7):. PubMed ID: 28640225
[TBL] [Abstract][Full Text] [Related]
15. Biological evaluation of a novel sorafenib analogue, t-CUPM.
Wecksler AT; Hwang SH; Liu JY; Wettersten HI; Morisseau C; Wu J; Weiss RH; Hammock BD
Cancer Chemother Pharmacol; 2015 Jan; 75(1):161-71. PubMed ID: 25413440
[TBL] [Abstract][Full Text] [Related]
16. Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism.
Wang H; Dong L; Qu F; He H; Sun W; Man Y; Jiang H
Pharm Biol; 2020 Dec; 58(1):352-356. PubMed ID: 32298152
[No Abstract] [Full Text] [Related]
17. Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism.
Sun H; Wang J; Lv J
Pharm Biol; 2019 Dec; 57(1):550-554. PubMed ID: 31429612
[No Abstract] [Full Text] [Related]
18. Ontogeny and sorafenib metabolism.
Zimmerman EI; Roberts JL; Li L; Finkelstein D; Gibson A; Chaudhry AS; Schuetz EG; Rubnitz JE; Inaba H; Baker SD
Clin Cancer Res; 2012 Oct; 18(20):5788-95. PubMed ID: 22927483
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylation.
Sugiyama M; Fujita K; Murayama N; Akiyama Y; Yamazaki H; Sasaki Y
Drug Metab Dispos; 2011 May; 39(5):757-62. PubMed ID: 21266595
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
Zhang H; Ya G; Rui H
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]